Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1976 Nov;29(11):959–966. doi: 10.1136/jcp.29.11.959

Adenosquamous carcinoma of the endometrium.

M T Haqqani, H Fox
PMCID: PMC476239  PMID: 1002838

Abstract

An adenosquamous carcinoma of the endometrium is one which contains both malignant glandular and malignant squamous components; such tumours are considered rare in Britain but are thought to account for nearly one-third of all endometrial neoplasms in the United States. A survey of 675 cases of endometrial cancer seen during the period 1956-75 showed that the incidence of adenosquamous carcinoma was 5%, an incidence that remained static during this 20-year period. The principal difficulties encountered in the diagnosis of these neoplasms are in identifying the squamous component as such and in differentiating it from benign metaplastic squamous epithelium. The prognosis for patients with an endometrial adenosquamous carcinoma is very much worse than for women with a pure adenocarcinoma, and because these neoplasms are often wrongly identified it is possible that the currently accepted prognoses for both pure adenocarcinoma and adenoacanthoma of the endometrium may have to be revised. There appears to be a true variation in the incidence of this neoplasm between Britain and the United States.

Full text

PDF
959

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa M., Ng A. B. Mixed (adenosquamous) carcinoma of the endometrium: electron microscopic observations. Cancer. 1973 Feb;31(2):385–397. doi: 10.1002/1097-0142(197302)31:2<385::aid-cncr2820310217>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  2. BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
  3. Badib A. O., Kurohara S. S., Vongtama V. Y., Selim M. A., Webster J. H. Biologic behavior of adenoacanthoma of endometrium. Am J Obstet Gynecol. 1970 Jan 15;106(2):205–209. doi: 10.1016/0002-9378(70)90264-4. [DOI] [PubMed] [Google Scholar]
  4. CHARLES D. ENDOMETRIAL ADENOACANTHOMA; A CLINICOPATHOLOGICAL STUDY OF 55 CASES. Cancer. 1965 Jun;18:737–750. doi: 10.1002/1097-0142(196506)18:6<737::aid-cncr2820180611>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  5. Liu C. T. A study of endometrial adenocarcinoma with emphasis on morphologically variant types. Am J Clin Pathol. 1972 May;57(5):562–573. doi: 10.1093/ajcp/57.5.562. [DOI] [PubMed] [Google Scholar]
  6. Morrison D. L. Adenoacanthoma of the uterine body. J Obstet Gynaecol Br Commonw. 1966 Aug;73(4):605–610. [PubMed] [Google Scholar]
  7. NOVAK E. R., NALLEY W. B. Uterine adenoacanthoma. Obstet Gynecol. 1957 Apr;9(4):396–402. [PubMed] [Google Scholar]
  8. Ng A. B. Mixed carcinoma of the endometrium. Am J Obstet Gynecol. 1968 Oct 15;102(4):506–515. doi: 10.1016/0002-9378(68)90531-0. [DOI] [PubMed] [Google Scholar]
  9. Ng A. B., Reagan J. W., Storaasli J. P., Wentz W. B. Mixed adenosquamous carcinoma of the endometrium. Am J Clin Pathol. 1973 Jun;59(6):765–781. doi: 10.1093/ajcp/59.6.765. [DOI] [PubMed] [Google Scholar]
  10. Pokoly T. A comparison of the clinical behavior of uterine adenocarcinomas and adenoacanthomas. Am J Obstet Gynecol. 1970 Dec 1;108(7):1080–1084. doi: 10.1016/0002-9378(70)90456-4. [DOI] [PubMed] [Google Scholar]
  11. Reagan J. W. Cellular pathology and uterine cancer. Ward Burdick Award address. Am J Clin Pathol. 1974 Aug;62(2):150–164. doi: 10.1093/ajcp/62.2.150. [DOI] [PubMed] [Google Scholar]
  12. Silverberg S. G., Bolin M. G., DeGiorgi L. S. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study. Cancer. 1972 Nov;30(5):1307–1314. doi: 10.1002/1097-0142(197211)30:5<1307::aid-cncr2820300524>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  13. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  14. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES